Search
for
Sort by
Research 871–900 of 1000+
- Obesity and polycystic ovary syndrome
- Polycystic Ovary Syndrome
- Management of Hair Loss
- Ovarian leukocyte distribution and cytokine/chemokine mRNA expression in follicular fluid cells in women with polycystic ovary syndrome
- Endocrine Therapy–Induced Alopecia in Patients With Breast Cancer
- Dermatology of androgen-related disorders
- Acute diffuse and total alopecia: A new subtype of alopecia areata with a favorable prognosis
- Relationships between cerebrospinal fluid GABAergic neurosteroid levels and symptom severity in men with PTSD
- The Role of Oral Contraceptives in the Treatment of Hyperandrogenic Disorders
- Differential Expression of miR-93 and miR-21 in Granulosa Cells and Follicular Fluid of Polycystic Ovary Syndrome Associating with Different Phenotypes
- Regulation of masculinization: androgen signalling for external genitalia development
- Alternative treatment of polycystic ovary syndrome: pre-clinical and clinical basis for using plant-based drugs
- Evidence-based approach to cutaneous hyperandrogenism in women
- Evidence for Increased 5α-Reductase Activity During Early Childhood in Daughters of Women With Polycystic Ovary Syndrome
- Acquired hypertrichosis lanuginosa: Case report and review of the literature
- Interventions for female pattern hair loss
- Androgen Deprivation Therapy in Prostate Cancer: Focusing on Sexual Side Effects
- Polycystic Ovarian Syndrome: Long-Term Health Consequences
- Intermittent Use of Testosterone Inactivating Pharmaceuticals Using Finasteride Prolongs the Time Off Period
- Effects of Curcumin on Glycemic Control and Lipid Profile in Polycystic Ovary Syndrome: Systematic Review with Meta-Analysis and Trial Sequential Analysis
- Controversies Regarding Transdermal Androgen Therapy in Postmenopausal Women
- Polycystic ovary syndrome: A review for dermatologists
- Long-term use of 5α-reductase inhibitors and the risk of male breast cancer
- The VEGF +405 G>C 5' untranslated region polymorphism and risk of PCOS: a study in the South Indian Women
- Obesity and the Polycystic Ovary Syndrome
- Combined Oral Contraception and Bicalutamide in Polycystic Ovary Syndrome and Severe Hirsutism: A Double-Blind Randomized Controlled Trial
- Ginsenoside F2 Reduces Hair Loss by Controlling Apoptosis through the Sterol Regulatory Element-Binding Protein Cleavage Activating Protein and Transforming Growth Factor-β Pathways in a Dihydrotestosterone-Induced Mouse Model
- Overexpression of IL-18 in the Proliferative Phase Endometrium of Patients With Polycystic Ovary Syndrome
- Impact of Treatment with Rosiglitazone or Metformin on Biomarkers for Insulin Resistance and Metabolic Syndrome in Patients with Polycystic Ovary Syndrome
- Physiopathological role of the enzymatic complex 5α-reductase and 3α/β-hydroxysteroid oxidoreductase in the generation of progesterone and testosterone neuroactive metabolites